Endometrial Cancer Trial, Recruiting NCT06841653 Sponsor: Regina Elena Cancer Institute Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT06841653
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are over 18 years of age
  • People who have been diagnosed (confirmed by tissue testing) with endometrial hyperplasia (thickening of the uterine lining), endometrioid adenocarcinoma of the endometrium (a type of uterine cancer), or who have a healthy uterine lining and are already scheduled to have a full hysterectomy for an unrelated, non-cancerous condition
  • People who are willing to provide written consent to take part in the study and to allow their data to be used
  • For the retrospective part of the study (involving past patients): tissue samples must be adequately stored at the institute's biobank, and at least 2 years of follow-up records must be available

Who may not be able to join:

  • People with serious ongoing health conditions that are not well managed with current medical treatment
  • People with an active infection inside the uterine cavity (a condition where pus collects in the uterus)
  • People who have been diagnosed with another cancer at the same time
  • People who have received treatment before surgery aimed at shrinking a tumour (confirm with trial site)
  • People who have previously had radiotherapy to the pelvic area
  • People who are currently receiving or have received hormone therapy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 06 52666974

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Regina Elena Cancer Institute
Registry
ClinicalTrials.gov
Start date
20 June 2024
Est. completion
20 June 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

OS (overall survival); DSF (disease-free survival)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov